CG Oncology大涨30%:溶瘤病毒CG0070三期临床提前一年出结果,乐普生物拥有大中华区权益

医药笔记
Jan 10

▎Armstrong2026年1月9日,CG Oncology宣布溶瘤病毒CG0070治疗中风险NMIBC的关键三期临床PIVOT-006预计将于2026年上半年读书顶线数据,比原本预期的时间表提前了接近一年,源于入组速度远超预期。受此消息影响,CG Oncology当天股价大涨29%,市值达到44亿美元。Cretostimogene为一款工程化5型腺病毒溶瘤病毒,嵌入了两种编码基因-肿瘤选择性...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10